Mental Health Home > Desvenlafaxine

Desvenlafaxine is a medication often prescribed for the treatment of depression. It is an extended-release tablet that only needs to be taken once a day. By acting on certain chemicals in the brain (serotonin and norepinephrine), it can help improve the symptoms of depression. While most people tolerate the medicine well, potential side effects include nausea, dizziness, and insomnia.

What Is Desvenlafaxine?

Desvenlafaxine succinate (Pristiq®) is a prescription medication used to treat depression. It comes in an extended-release tablet, meaning the medicine is released slowly into your body over time. Because desvenlafaxine is long-acting, it is taken just once a day.
(Click What Is Desvenlafaxine Used For? for more information, including possible off-label uses.)

Are There Side Effects?

As with any medicine, side effects are possible with desvenlafaxine. However, not everyone who takes the drug will experience side effects. In fact, most people tolerate it quite well.
If side effects do occur, in most cases, they are minor and either require no treatment or can be treated easily by you or your healthcare provider. Serious side effects are less common.
Common side effects of desvenlafaxine include but are not limited to:
(Click Side Effects of Desvenlafaxine to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.